Kre-Alkalyn® Buffered Creatine Research Article By Dr. Jeff Golini Published In Peer-Reviewed Journal Through Emory University School Of Medicine

Billings, MT, Oct. 15, 2015 - All American Pharmaceutical is pleased to announce that Dr. Jeff Golini's research article, "The Effect of an Alkaline Buffered Creatine (Kre-Alkalyn®), on Cell Membrane Behavior, Protein Synthesis, And Cisplatin-Mediated Cellular Toxicity", has been published by Integrative Molecular Medicine, through Emory University School of Medicine. Three previous research articles authored by Dr. Golini have appeared in other respected peer-reviewed journals.

Integrative Molecular Medicine (IMM) is a peer-reviewed, online open access journal dedicated to a new research discipline at the interface between clinical research and basic biology.

Dr. Golini serves as Executive Scientist for All American Pharmaceutical, a cutting-edge contract manufacturing and research facility that develops novel nutritional compounds and sports supplements, such as Kre-Alkalyn and Karbolyn, while also conducting research to promote improved human health and performance.

"Emory University maintains one of the finest medical schools in our nation. Having my research efforts recognized through one of their peer-reviewed journals is an honor", states Dr. Golini, "and represents yet another significant milestone for All American Pharmaceutical."

To learn more about All American Pharmaceutical and its services and products, visit the website at www.allamericanpharmaceutical.com; or listen to Dr. Golini as the host of The EFX Sports Show on ESPN Billings.

For more information, call 406-245-5793 or email: scientist@allamph.com.